Category

Asia Pacific Nuclear Medicine Market - Forecasts From 2018 To 2023

114 pages
Published on : May 2019
Report Code : KSI061610990

Description

The Asia-Pacific nuclear medicine market is predicted to witness a compound annual growth rate of XX.XX% during the forecast period to reach a total market size of US$XX.XX billion by 2023, increasing from US$XX.XX billion in 2017. Nuclear medicine is a medical domain which involves the use of radio-pharmaceuticals to diagnose and treat diseases in a painless way. The higher incidences of prevalence of cancer and cardiac ailments, and higher adoption of SPECT and PET techniques with improved technologies will lead to an increased adoption of nuclear medicine technology in Asia Pacific Region. Additionally, rising public awareness about better healthcare and growing awareness in medical professionals is further pushing the nuclear medicine market growth. However, factors such as short half-life of radiopharmaceuticals and stringent regulatory guidelines by various government bodies are likely to impede the growth of nuclear medicine demand.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the Nuclear Medicine value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the market.

Major industry players profiled as part of the report are Fullerton Healthcare Corporation Limited, FUJIFILM Holdings Corporation, Curium and Lantheus Medical Imaging, Inc. among others.

Segmentation

The Asia Pacific Nuclear Medicine market has been analysed through following segments:

By Technology

PET

SPECT


By Application

Central Nervous System

Endocrine

Skeletal

Gastrointestinal

Genitourinary

Pulmonary


By End User 

Hospitals

Diagnostic Centres

Research Institutions


By Country

Asia Pacific

India

China

Japan

Others


Target audience

Manufacturers

Suppliers

Distributors

Service Providers

Government Agencies

Research Organizations

Consultants


Key insights offered

What will be the Asia Pacific Nuclear Medicine market size from 2017 to 2023?

How are the major drivers and restraints affecting the global Asia Pacific Nuclear Medicine market growth and the opportunities which exist for key vendors?

Which segment and region will drive or lead the market growth and why?

A comprehensive analysis of competitive landscape and key market participants’ behaviour

Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.

OUR CLIENTS